What development phase is Clinacox in?

Clinacox is FDA-approved (marketed).

What is the generic name of Clinacox?

DICLAZURIL is the generic (nonproprietary) name of Clinacox.

Last reviewed 2026-04-20 · How we verify

Clinacox (DICLAZURIL)

FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	DICLAZURIL
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) (NA)
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Clinacox CI brief — competitive landscape report
Clinacox updates RSS · CI watch RSS